openPR Logo
Press release

Clinical Decision Support Systems Market Hits US$ 2.2 Billion by 2027 Grow CAGR 7.9% Leading Key Players are Clinical Decision Support Systems (CDSS) Market are Cerner Corporation (US), Change Healthcare (US), Epic Systems (US), MEDITECH (US), Philips Hea

11-22-2022 04:05 PM CET | Health & Medicine

Press release from: MarketsandMakets

Clinical Decision Support Systems Market

Clinical Decision Support Systems Market

Clinical Decision Support Systems Market by Component (Services, Software), Delivery (On-premise, Cloud), Product (Standalone, Integrated), Application (Advanced, Therapeutic, Diagnostic), Interactivity (Active, Passive) - Global Forecasts to 2027", published by MarketsandMarkets™, the global CDSS market is projected to reach USD 2.2 Billion by 2027 from USD 1.5 Billion in 2022, at a CAGR of 7.9% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18085342&utm_source=OPenpr&utm_medium=referral

Key Market Players:
Prominent players in this Clinical Decision Support Systems (CDSS) Market are Cerner Corporation (US), Change Healthcare (US), Epic Systems (US), MEDITECH (US), Philips Healthcare (Netherlands), Wolters Kluwer N.V. (Netherlands), Zynx Health (US), Elsevier B.V. (UK), IBM Watson Health (US), Allscripts Healthcare LLC (US), athenahealth (US), NextGen Healthcare (US), Siemens Healthineers (US), EBSCO Health (US), GE Healthcare (US), eClinicalWorks (US), RAMPMedical (Germany), The Medical Algorithms Company Limited (UK), Hera-MI (France), CureMD Healthcare (US), CareCloud, Inc (US), Visual DX (US), Stanson Health (US), First Databank, Inc (US), and Strata Decision Technology (US).

The growth of this market is driven by the implementation of government regulations and initiatives to promote the adoption of HCIT solutions, increasing adoption of CDSS-enabled EHRs, growing collaborations and partnerships between stakeholders, rising incidence of medication errors, and the development of mHealth and big data tools. However, high investment requirements for the implementation of CDSS and inadequate interoperability coupled with rising data security concerns are factors expected to restrain the growth of this market during the forecast period.

Impact of Covid-19 on The Clinical Decision Support Systems Market

Due to the COVID-19 outbreak, medical practices of all sizes are under immense pressure, and healthcare facilities worldwide have been overwhelmed by the large number of patients visiting them daily. The emergence of this pandemic drives the demand for correct diagnosis and treatment devices in several countries across the globe. In this regard, clinical decision support systems have proven to be very compatible, as they allow healthcare providers and physicians to monitor patients using digitally connected noninvasive devices. Moreover, the rapid increase in number of patients across the globe resulted in a shortage of hospital beds and healthcare workers. This has driven the demand for medical devices for vital signs monitoring. The COVID-19 pandemic also increased the need for social distancing among physicians and patients, which has driven the demand for telehealth solutions and virtual consultation. Various players in this market have introduced COVID-19-associated features into their existing EHRs, which are being made available to users free of cost.

Software segment is expected to grow at the highest rate during the forecast period

The CDSS market is segmented based on components: services, software, and hardware. In 2021, the services segment accounted for the largest share of this market. Growth in this segment can be attributed to the recurring nature of services such as training and development, installation, consulting, and maintenance.

The On-premise solutions segment is estimated to account for the largest share of the Clinical decision support systems market in 2022

Clinical decision support systems are delivered to end users through on-premise and cloud-based modes. The on-premise mode of delivery accounted for the largest share of the clinical decision support systems market in 2021. The cloud-based mode of delivery, on the other hand, is estimated to grow at the highest CAGR due to comparatively lower capital expenses and operational costs incurred in this model, alongside its scalability, flexibility, and affordability.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=18085342&utm_source=OPenpr&utm_medium=referral

Conventional CDSS segment accounted for the largest share of the global Clinical decision support systems market

Based on application, the CDSS market is segmented into conventional CDSS and advanced CDSS. In 2021, the conventional CDSS segment accounted for the largest share of the market, primarily owing to the increasing adoption of CDSS by healthcare organizations to provide guidance & reminders to caregivers at the point-of-care.

Integrated CDSS segment accounted for the largest share of the global Clinical decision support systems market

Based on product, the CDSS market is segmented into integrated CDSS and standalone CDSS. In 2021, the integrated CDSS segment accounted for the largest share of the market. The large share of this segment can be attributed to the growing deployment of integrated CDSS in healthcare settings.

The therapeutic CDSS segment is expected to grow with the highest CAGR during the forecast period

Based on type, the clinical decision support systems market is segmented into therapeutic CDSS and diagnostic CDSS. The therapeutic CDSS segment dominated this market in 2021. This segment is estimated to grow at a higher CAGR during the forecast period. This segments large share and high growth rate can be attributed therapeutic CDSS being preferred by clinicians over diagnostic CDSS as it can be better integrated into clinical workflows. It is also convenient to use, as it doesn't restrict the healthcare provider's autonomy.

Knowledge-based CDSS segment accounted for the largest share of the global Clinical decision support systems market

Based on the model, the CDSS market is segmented into knowledge-based CDSS and non-knowledge-based CDSS. In 2021, the knowledge-based CDSS segment accounted for the largest share of the market. This segment is also estimated to register the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the several beneficial functionalities of these systems, such as helping clinicians with knowledge-based reasoning to make clinical decisions in uncertainties. These systems can also be integrated into clinical workflows and are less prone to errors than non-knowledge-based systems.

The Active CDSS segment is expected to grow with the highest CAGR during the forecast period

Based on the interactivity level, the CDSS market can be segmented into active CDSS and passive CDSS. The active CDSS segment accounted for the largest share of the market in 2021 and is projected to grow at the highest CAGR during the forecast period.

Inpatient settings accounted for the largest share of the global Clinical decision support systems market

Based on setting, the CDSS market is segmented into inpatient and ambulatory care settings. Inpatient settings accounted for the largest share of the CDSS market in 2021. Inpatient settings need to capture and analyze large volumes of patient data, which results in the increasing adoption of integrated healthcare IT modules.

North America to dominate the Clinical decision support systems market in 2022

North America accounted for the largest share of the global clinical decision support systems (CDSS) market in 2021. The large share of the North American market can be attributed to the significant investments in HCIT solutions, regulatory mandates favoring the implementation of CDSS, the presence of major market players in the region, and the rising number of medication errors in the US and Canada.

The Asia Pacific market is projected to register the highest CAGR during the forecast period, owing to the factors such as the presence of a large senior population, improved government legislation, the high burden of chronic diseases, and the growing focus of various market players on emerging Asian countries are expected to drive the growth of the CDSS market in Asia.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=18085342&utm_source=OPenpr&utm_medium=referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Decision Support Systems Market Hits US$ 2.2 Billion by 2027 Grow CAGR 7.9% Leading Key Players are Clinical Decision Support Systems (CDSS) Market are Cerner Corporation (US), Change Healthcare (US), Epic Systems (US), MEDITECH (US), Philips Hea here

News-ID: 2816985 • Views: 201

More Releases from MarketsandMakets

Advanced Wound Care Market worth $17.7 billion by 2027 - Leading Key Players are …
Advanced Wound Care Market is valued at an estimated USD 11.3 billion in 2022 and is projected to reach USD 17.7 billion by 2027, at a CAGR of 9.4% during the forecast period according to a new report by MarketsandMarkets™. Growth in this market is mainly driven by factors such as the rising prevalence of diseases & conditions that impair wound healing capabilities, rising costs associated with chronic wounds, and
APAC Spatial Genomics & Transcriptomics Market worth $152 million by 2027 - Lead …
APAC Spatial Genomics & Transcriptomics Market is projected to reach USD 152 million by 2027 from USD 64 million in 2022, at a CAGR of 18.9% during the forecast period according to a new report by MarketsandMarkets™. The major factors driving the growth of the spatial genomics and transcriptomics market are the increasing adoption of spatial genomics and transcriptomics techniques for drug discovery & development and the increasing R&D investments
APAC In Situ Hybridization Market worth $744 million by 2027 - Leading Key Playe …
APAC In Situ Hybridization Market is projected to reach USD 744 million by 2027 from USD 363 million in 2022, at a CAGR of 15.4% during the forecast period according to a new report by MarketsandMarkets™. Key drivers of the APAC in situ hybridization market include growing cases of cancer in the region coupled with rising incidence of genetic disorders. Moreover, growing adoption of companion diagnostics will also propel the
Minimal Residual Disease Testing Market worth $2.3 billion by 2027 - Leading Key …
Minimal Residual Disease Testing Market is valued at an estimated USD 1.2 Billion in 2022 and is projected to reach USD 2.3 Billion by 2027, at a CAGR of 14.0% during the forecast period according to a new report by MarketsandMarkets™. Increasing prevalence of cancer and hematological malignancies, rising initiatives undertaken by government bodies to create awareness about cancer, and increasing collaborations are factors driving the growth of the global

All 5 Releases


More Releases for CDSS

Clinical Decision Support Systems (CDSS) Market Report
The findings reviewed by GME stated that the Clinical Decision Support Systems (CDSS) Market will expand with a high CAGR value by 2026. Increasing awareness of the advantages of digital solutions, the development of medical infrastructure in developing countries, and the increasing population, as well as the increasing chronic diseases, are becoming significant growth factors for the market. Furthermore, the ongoing pandemic has also contributed to the growing demand for
Global Clinical Decision Support System (CDSS) Market Size, Status and Forecast
A clinical decision support system (CDSS) is an application that analyzes data to help healthcare providers make decisions and improve patient care. It is a variation of the decision support system (DSS) commonly used to support business management. In 2017, the global Clinical Decision Support System (CDSS) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR
Global Clinical Decision Support Systems (CDSS) Market 2019 By Agfa Healthcare, …
The Global Clinical Decision Support Systems (CDSS) market report offers a detailed analysis of the global Clinical Decision Support Systems (CDSS) market. It also highlights the novel contributors and existing players in the Clinical Decision Support Systems (CDSS) market. This report summarizes the global Clinical Decision Support Systems (CDSS) market. It emphasizes on the leading performers in the global market. The global Clinical Decision Support Systems (CDSS) market report offers
Clinical Decision Support System (CDSS) Market Size, Share, Development by 2023
New report published by Global Info Research which offers insights on the global Clinical Decision Support System (CDSS) market. A clinical decision support system (CDSS) is an application that analyzes data to help healthcare providers make decisions and improve patient care. It is a variation of the decision support system (DSS) commonly used to support business management. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-clinical-decision-support-system-cdss-market_p87085.html Global Clinical
Clinical Decision Support System (CDSS) Market Report Forecasts High Growth by 2 …
According to the report, “Clinical Decision Support System (CDSS) Market By Components (Hardware, Software and Services ), Applications (Drug Allergy Alerts, Drug-Drug Interactions, Drug Reminders Clinical Guidelines, Clinical Reminders, Drug Dosing Support and Others), Models (Knowledge-Based and Non-Knowledge-Based), Mode of Delivery (Web-based, On-premises, and Cloud computing), Products (Integrated and Standalone) and By Geography (North America, Europe, Asia Pacific & Rest Of The World) Report Forecast - 2013 To 2021”, the
Clinical Decision Support System (CDSS) Market : Market and Growth Analysis
Global Clinical Decision Support System (CDSS) Market: Overview A clinical decision support system (CDSS) refers is used in the healthcare sector to aid healthcare professionals in decision making tasks. Doctors, nurses, and other healthcare providers utilize CDSS in the preparation of a diagnosis and its review. Such an evaluation of data assists the prediction of potential events ranging from medication interaction to disease symptoms. The global market for CDSS can be broadly